Advair Rotahaler is a combination inhaler that contains the corticosteroid fluticasone propionate and the long-acting beta-2 agonist salmeterol. It is prescribed to improve lung function and control symptoms in patients with asthma and chronic obstructive pulmonary disease. The fluticasone component reduces airway inflammation by modulating immune cells that release inflammatory mediators. The salmeterol component relaxes bronchial smooth muscle through stimulation of beta-2 receptors, leading to prolonged bronchodilation. Together, these actions facilitate easier breathing by decreasing swelling and maintaining airway patency during exposure to triggers. The medication therefore addresses the underlying pathophysiology of obstructive lung disease by targeting both inflammatory and bronchoconstrictive mechanisms.

Advair Rotahaler is a combination inhaler that contains the corticosteroid fluticasone propionate and the long-acting beta-2 agonist salmeterol. The corticosteroid reduces inflammation in the airways by inhibiting the release of inflammatory cytokines. The agonist binds to beta-2 receptors on bronchial smooth muscle, causing relaxation and bronchodilation. Together they improve airflow and reduce breathlessness in patients with chronic obstructive pulmonary disease. Pharmacodynamically, fluticasone decreases airway hyperresponsiveness, while salmeterol maintains sustained bronchodilation. The medication's mechanism targets both the inflammatory cascade and the contractile response of airway smooth muscle. This dual action addresses the underlying pathophysiology of chronic respiratory disease. The result is a sustained improvement in lung function and symptom control.

Advair Rotahaler is a combination inhaler that delivers fluticasone and salmeterol to help control asthma symptoms. One common side effect is irritation of the throat or mouth which may cause a sore throat or dry feeling. Some users may experience coughing or hoarseness after inhalation. Rarely the medication can lead to headaches or dizziness. Inhalation may occasionally cause tremors or an increased heart rate. Visual disturbances such as blurred vision have been reported in a small number of cases. These effects are generally mild and do not require stopping treatment unless they persist or worsen.

Headache may occur after using Advair Rotahaler. Some users report throat irritation or dry cough. Nausea and upset stomach are possible gastrointestinal reactions. Muscle aches or joint pain can appear in certain individuals. Elevated heart rate or palpitations have been documented. Visual disturbances such as blurred vision may develop rarely. Skin rash or itching can indicate an allergic response.